Smiling woman sitting in front of green wall at AlkermesSmiling woman sitting in front of green wall at AlkermesBlue Triangle graphic

News and Events

Sharing Stories of
Patients, Employees
and Communities

Explore Our Stories

Featured News

February 15, 2024

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024

Read more

January 03, 2024

Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI® (olanzapine and samidorpha...

Read more

December 14, 2023

Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk

Read more

See all press releases

Our Commitment to Responsibility

Corporate responsibility has always played a central role in our business and has proven even more critical in recent years as we navigated pressing public health and societal issues– a dynamic global pandemic, systemic racism in the U.S. and around the world, and a worsening climate change crisis. Guided by our purpose and values, we took actions to respond to these critical issues, while sharpening our focus on scientific and business excellence in our efforts to help people living with complex and difficult-to-treat diseases. Our most recent Corporate Responsibility Report expounds on these efforts.

Corporate Responsibility reports   

Our Stories

Each endeavor at Alkermes starts with collaboration and our shared commitment to make a difference for patients and our communitiesThese stories – which highlight our people, science and innovation, and leadership perspectives – showcase just a subset of what makes us proud to be part of Alkermes. Visit our full gallery of stories by clicking on the link below.

Laura Tan

Celebrating Women in STEM

In recognition of International Day of Women & Girls in Science, Laura Tan reflects on her career journey and the importance of creating opportunities for women in STEM.

Read the Q&A

Building on Our Heritage

Blair Jackson shares his thoughts on Alkermes' past and future as a neuroscience company.

Read More

Blair Jackson

Craig Hopkinson, M.D.

Learning from Patients: Our Commitment to the Narcolepsy Community

Hear from Craig Hopkinson, M.D. as he reflects on the unmet needs of people living with narcolepsy.

Read the post

Media Resources

Company Description

Alkermes applies its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A fully-integrated, global biopharmaceutical company, with U.S. locations in Massachusetts and Ohio, and locations in Dublin and Athlone, Ireland, we seek to make a meaningful difference in the way people manage their diseases. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized.

Media Inquiries

Email our media team

Company Logos

Download logos

Company Photo

Download photo

Corporate Fact Sheet

Download fact sheet 

Follow us on our social channels   

blue triangle graphic

Statements and Positions

The idea that a corporation can play a profoundly positive role in society is central to our vision. We believe it is our obligation to voice our beliefs about issues that impact the patients we serve and the communities in which we live and work.

Company Statement on the Invasion of Ukraine

Read our statement

Systemic Racism and Violence

Read our statement